Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 0.80% | 69.52 | 0.0% | $2214.61m | |
| NVAX | Novavax, Inc. | -16.77% | 124.42 | 96.5% | $1026.77m | |
| SRNE | Sorrento Therapeutics, Inc. | -11.92% | 12.41 | 1.5% | $731.21m | |
| GILD | Gilead Sciences, Inc. | 1.09% | 68.84 | 1.0% | $571.41m | |
| AMGN | Amgen, Inc. | 3.01% | 241.72 | 1.3% | $485.13m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 2.25% | 612.35 | 2.7% | $399.20m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 3.43% | 270.85 | 1.9% | $367.43m | |
| BIIB | Biogen, Inc. | 1.13% | 293.22 | 1.6% | $355.55m | |
| BNTX | BioNTech SE | 0.96% | 69.11 | 0.0% | $350.86m | |
| ILMN | Illumina, Inc. | 0.86% | 344.14 | 3.5% | $338.32m | |
| VXRT | Vaxart, Inc. | -14.42% | 9.20 | 0.0% | $262.52m | |
| ATNM | Actinium Pharmaceuticals, Inc. | -0.31% | 9.63 | 13.3% | $232.11m | |
| EBS | Emergent BioSolutions, Inc. | 6.00% | 129.67 | 6.4% | $188.23m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.52% | 102.78 | 2.0% | $167.84m | |
| SGEN | Seattle Genetics, Inc. | 3.46% | 158.79 | 6.0% | $158.72m |
Company Profile
Personalis, Inc. engages in the provision of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in 2011 and is headquartered in Menlo Park, CA.